Seeing Is Believing
RNA is currently covered by 10 analysts with an average price target of $90.66. This is a potential upside of $20.86 (29.89%) from yesterday's end of day stock price of $69.8.
Avidity Biosciences 's activity chart (see below) currently has 73 price targets and 81 ratings on display. The stock rating distribution of RNA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 65.34% with an average time for these price targets to be met of 363.23 days.
Highest price target for RNA is $96, Lowest price target is $59, average price target is $71.5.
Most recent stock forecast was given by RITU BARAL from TD COWEN on 29-Oct-2025. First documented stock forecast 07-Jul-2020.
Currently out of the existing stock ratings of RNA, 28 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$74
$4.15 (5.94%)
$78
5 days ago
(29-Oct-2025)
0/2 (0%)
$4.35 (6.25%)
Buy
$72
$2.15 (3.08%)
$75
6 days ago
(28-Oct-2025)
12/15 (80%)
$2.07 (2.96%)
283
Buy
$72
$2.15 (3.08%)
$61
6 days ago
(28-Oct-2025)
3/4 (75%)
$2.07 (2.96%)
285
Buy
$72
$2.15 (3.08%)
$18
7 days ago
(27-Oct-2025)
3/4 (75%)
$2 (2.86%)
989
Buy
$65
$-4.85 (-6.94%)
$65
7 days ago
(27-Oct-2025)
17/18 (94.44%)
$-5 (-7.14%)
255
What is RNA (Avidity Biosciences ) average time for price targets to be met?
Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences )?
Which analyst is the currently most bullish on RNA (Avidity Biosciences )?
Which analyst is the currently most reserved on RNA (Avidity Biosciences )?